HR 7828 · 117th Congress 2021–2023, ended

PRICED Act

Fact sheet

Latest action · May 18, 2022 Referred to the House Committee on Energy and Commerce.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 18, 2022
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act

This bill allows biosimilars to be marketed five years after the reference brand-name biological product is licensed. Currently, brand-name biological products are provided a 12-year marketing-exclusivity period.

This shortened marketing-exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill.

Cosponsors 10

Members who signed on, in the order they did. Signatures ran from May 18, 2022 to Jul 12, 2022, with 7 there on the day it was introduced.

SeatCosponsorSigned on
R-ARBruce WestermanOriginalMay 18, 2022
D-ILJesús G. "Chuy" GarcíaOriginalMay 18, 2022
D-TXLloyd DoggettOriginalMay 18, 2022
D-OHMarcy KapturOriginalMay 18, 2022
D-WIMark PocanOriginalMay 18, 2022
D-CARo KhannaOriginalMay 18, 2022
D-CTRosa L. DeLauroOriginalMay 18, 2022
D-ILRaja KrishnamoorthiMay 24, 2022
D-MIAndy LevinJul 12, 2022
D-WAPramila JayapalJul 12, 2022

Actions 2

Everything that happened, newest first.

  1. May 18, 2022Introduced in House
  2. May 18, 2022Referred to the House Committee on Energy and Commerce.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1898Affordable Medications ActRelated billMay 27, 2021
HR 8588Fair Care Act of 2022Related billNov 1, 2022

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 18, 2022Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.